Analyzing...
Loading company...
No significant concerns identified
Nothing flagged for monitoring
“Services business in Healthcare — Hospitals & Diagnostics.”
₹3,692 Cr service revenue.
Employee costs at 22.3% of revenue — primary cost driver.
“five to seven is a reasonable number”
“EBITDA, excluding Noida, grew by 11% year on year to INR 2,814 million with healthy margins of 25.”
“hope so, that we've seen the peak of the losses.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 13.9%▲ | 7.9% |
| ROCE | 15.5%▲ | 11.3% |
| Net Margin | 12.0%▲ | 9.3% |
| EBITDA Margin | 21.9% | 21.9% |
| Debt To Equity | 0.14x▼ | 0.16x |
| Employee Cost Ratio | 22.30x | - |
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | ₹4,182 Cr +13.3% | ₹3,692 Cr +12.7% | ₹3,275 Cr +21.6% | ₹2,694 Cr |
| Other Income | ₹85 Cr +7.3% | ₹79 Cr +5.9% | ₹75 Cr +15.0% | ₹65 Cr |
| Total Income | ₹4,267 Cr +13.1% | ₹3,771 Cr +12.6% | ₹3,350 Cr +21.4% | ₹2,759 Cr |
| COGS | ₹964 Cr +9.6% | ₹880 Cr +15.8% | ₹759 Cr +21.4% | ₹625 Cr |
| ₹3,555 Cr +15.6% | ₹3,074 Cr +12.9% | ₹2,723 Cr +17.9% | ₹2,310 Cr | |
| Profit Before Tax | ₹661 Cr +2.2% | ₹647 Cr +3.2% | ₹627 Cr +39.6% | ₹449 Cr |
| Exceptional Items | (₹51 Cr) -2.0% | (₹50 Cr) | ₹0.00 Cr | ₹0.00 Cr |
| ₹147 Cr -11.2% | ₹166 Cr +11.3% | ₹149 Cr +21.0% | ₹123 Cr | |
| Net Profit | ₹514 Cr +6.7% | ₹481 Cr +0.7% | ₹478 Cr +46.6% | ₹326 Cr |
| Profit (Owners) | ₹514 Cr +6.7% | ₹481 Cr +0.7% | ₹478 Cr +46.6% | ₹326 Cr |
| Minority Interest | (₹0.08 Cr) +33.6% | (₹0.12 Cr) +11.2% | (₹0.13 Cr) | ₹0.00 Cr |
| Other Comprehensive Income | (₹2 Cr) -249.9% | (₹0.67 Cr) +28.6% | (₹0.94 Cr) ↓ Decline | ₹1 Cr |
| EPS | ₹19.13 | ₹17.92 | ₹17.81 | ₹12.16 |
| Diluted Shares | ₹27 Cr | ₹27 Cr | ₹27 Cr | ₹27 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Global Health Limited has informed the Exchange about Schedule of meet
Global Health Limited has informed the Exchange about General Updates on establishment of medical college.
Global Health Limited has informed the Exchange about Schedule of meet
Global Health Limited has informed the Exchange regarding Allotment of 15900 Shares.
Global Health Limited has informed the Exchange about Announcement under Regulation 30 of Listing regulations for Earning Call Transcript.
Global Health Limited has informed the Exchange about Link of Recording
Global Health Limited has informed the Exchange about Copy of Newspaper Publication
Global Health Limited has informed the Exchange that Board of Directors at its meeting held on May 14, 2026, recommended Final Dividend of Rs. 0.50 per equity share.
Global Health Limited has informed the Exchange regarding Grant of 10000 Options.
Global Health Limited has informed the Exchange regarding a press release dated April 27, 2026, titled Medanta Expands Indore Presence with Takeover of 80 Bed Cancer Hospital".
Global Health Limited has informed the Exchange about Capacity addition
Global Health Limited has informed the Exchange regarding Outcome of Board Meeting held on April 27, 2026.
Global Health Limited has informed the Exchange regarding Allotment of 61500 Shares.
Global Health Limited has informed the Exchange about Schedule of meet
Global Health Limited has informed the Exchange regarding a press release dated March 25, 2026, titled "Medanta to set up a 400-bed hospital in the centre of Varanasi, further strengthening its Uttar...